Genpact Stock Plummets to New 52-Week Low at $37.50

Genpact has reached a new 52-week low, trading at USD 37.50 as of November 3, 2025. This marks a significant decline for the small-cap company, which operates within the miscellaneous industry and has a market capitalization of USD 7,759 million. Over the past year, Genpact's performance has been notably below that of the S&P 500, with a return of 15.94% compared to the index's 19.89%.
Despite the recent downturn, Genpact maintains a relatively low debt-to-equity ratio of 0.27, indicating a conservative approach to leverage. The company has demonstrated high management efficiency, reflected in a return on equity of 20.86%. However, its net profit for the first nine months has decreased by 23.05%, raising questions about its profitability trajectory.

The stock's price-to-earnings ratio stands at 14.00, while its price-to-book ratio is 3.00. With a dividend yield of 150.73%, Genpact continues to attract attention, although its recent performance has not aligned with broader market trends. The stock's 52-week high was recorded at USD 56.76, highlighting the volatility in its price movements.